Individualizing immunosuppression for heart transplantation: strategies for the next decade.
Valantine
H A
HA
Division of Cardiovascular Medicine, Stanford University Medical Center, California, USA.
D003131:Combined Modality Therapy; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000517:prevention & control; D016027:Heart Transplantation / Q000276:immunology*; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods* / Q000639:trends; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D013601:T-Lymphocytes / Q000276:immunology
D007166:Immunosuppressive Agents